| | | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | |
|---|
|
| | SIP | IP | CI | | Olmetec Plus 20/12,5 | 28 Tablet(s) | 12.59 | 30.00 | 10 % | | Coated tablets: 2 Active Agents | Daiichi Sankyo
(Schweiz) AG | B / SL / SO | FB | G |
| | SIP | IP | CI | | Olmetec Plus 20/12,5 | 98 Tablet(s) | 37.44 | 56.80 | 10 % | | Coated tablets: 2 Active Agents | Daiichi Sankyo
(Schweiz) AG | ● B / SL / SO | FB | G |
| | SIP | IP | CI | | Olmetec Plus 20/25 | 28 Tablet(s) | 12.59 | 30.00 | 10 % | | Coated tablets: 2 Active Agents | Daiichi Sankyo
(Schweiz) AG | B / SL / SO | FB | G |
| | SIP | IP | CI | | Olmetec Plus 20/25 | 98 Tablet(s) | 37.44 | 56.80 | 10 % | | Coated tablets: 2 Active Agents | Daiichi Sankyo
(Schweiz) AG | B / SL / SO | FB | G |
| | SIP | IP | CI | | Olmetec Plus 40/12,5 | 28 Tablet(s) | 16.06 | 33.70 | 10 % | | Coated tablets: 2 Active Agents | Daiichi Sankyo
(Schweiz) AG | B / SL / SO | FB | G |
| | SIP | IP | CI | | Olmetec Plus 40/12,5 | 98 Tablet(s) | 47.76 | 67.95 | 10 % | | Coated tablets: 2 Active Agents | Daiichi Sankyo
(Schweiz) AG | ● B / SL / SO | FB | G |
| | SIP | IP | CI | | Olmetec Plus 40/25 | 28 Tablet(s) | 16.06 | 33.75 | 10 % | | Coated tablets: 2 Active Agents | Daiichi Sankyo
(Schweiz) AG | B / SL / SO | FB | G |
| | SIP | IP | CI | | Olmetec Plus 40/25 | 98 Tablet(s) | 47.76 | 67.95 | 10 % | | Coated tablets: 2 Active Agents | Daiichi Sankyo
(Schweiz) AG | B / SL / SO | FB | G |
| | | IP | CI | | Votum plus 20/12.5 | 28 Tablet(s) | 11.65 | 29.05 | 10 % | | Coated tablets: 2 Active Agents | A. Menarini GmbH | B / SL / SO | FB | G |
| | | IP | CI | | Votum plus 20/12.5 | 98 Tablet(s) | 34.63 | 53.90 | 10 % | | Coated tablets: 2 Active Agents | A. Menarini GmbH | B / SL / SO | FB | G |
| | | IP | CI | | Votum plus 20/25 | 28 Tablet(s) | 11.65 | 29.05 | 10 % | | Coated tablets: 2 Active Agents | A. Menarini GmbH | B / SL / SO | FB | G |
| | | IP | CI | | Votum plus 20/25 | 98 Tablet(s) | 34.63 | 53.90 | 10 % | | Coated tablets: 2 Active Agents | A. Menarini GmbH | B / SL / SO | FB | G |
| | | IP | CI | | Votum plus 40/12.5 | 28 Tablet(s) | 14.86 | 32.50 | 10 % | | Coated tablets: 2 Active Agents | A. Menarini GmbH | B / SL / SO | FB | G |
| | | IP | CI | | Votum plus 40/12.5 | 98 Tablet(s) | 44.19 | 64.25 | 10 % | | Coated tablets: 2 Active Agents | A. Menarini GmbH | B / SL / SO | FB | G |
| | | IP | CI | | Votum plus 40/25 | 28 Tablet(s) | 14.86 | 32.50 | 10 % | | Coated tablets: 2 Active Agents | A. Menarini GmbH | B / SL / SO | FB | G |
| | | IP | CI | | Votum plus 40/25 | 98 Tablet(s) | 44.19 | 64.25 | 10 % | | Coated tablets: 2 Active Agents | A. Menarini GmbH | B / SL / SO | FB | G |
| | | IP | CI | | Co-Olmesartan Spirig HC 20
mg/12,5 mg | 30 | 10.92 | 28.30 | 10 % | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Co-Olmesartan Spirig HC 20
mg/12,5 mg | 100 | 32.47 | 51.70 | 10 % | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Co-Olmesartan Spirig HC 20
mg/25 mg | 30 | 10.92 | 28.30 | 10 % | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Co-Olmesartan Spirig HC 20
mg/25 mg | 100 | 32.47 | 51.70 | 10 % | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Co-Olmesartan Spirig HC 40
mg/12,5 mg | 30 | 13.93 | 31.55 | 10 % | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Co-Olmesartan Spirig HC 40
mg/12,5 mg | 100 | 41.43 | 61.45 | 10 % | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Co-Olmesartan Spirig HC 40
mg/25 mg | 30 | 13.93 | 31.55 | 10 % | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Co-Olmesartan Spirig HC 40
mg/25 mg | 100 | 41.43 | 61.45 | 10 % | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Olmesartan Plus Sandoz 20
mg/12,5 mg | 28 | 10.70 | 28.05 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| | | IP | CI | | Olmesartan Plus Sandoz 20
mg/12,5 mg | 98 | 31.82 | 51.05 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| | | IP | CI | | Olmesartan Plus Sandoz 20
mg/25 mg | 28 | 10.70 | 28.05 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | ● B / SL / SG | FB | G |
| | | IP | CI | | Olmesartan Plus Sandoz 20
mg/25 mg | 98 | 31.82 | 51.05 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| | | IP | CI | | Olmesartan Plus Sandoz 40
mg/12,5 mg | 28 | 13.65 | 31.25 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | ● B / SL / SG | FB | G |
| | | IP | CI | | Olmesartan Plus Sandoz 40
mg/12,5 mg | 98 | 40.59 | 60.60 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| | | IP | CI | | Olmesartan Plus Sandoz 40
mg/25 mg | 28 | 13.65 | 31.25 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | ● B / SL / SG | FB | G |
| | | IP | CI | | Olmesartan Plus Sandoz 40
mg/25 mg | 98 | 40.59 | 60.60 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| | | IP | CI | | Olmesartan-HCT-Mepha Teva
20/12.5 mg | 28 | 10.70 | 28.05 | 10 % | | Coated tablets: Hydrochlorothiazidum 12.5 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Olmesartan-HCT-Mepha Teva
40/12.5 mg | 28 | 12.25 | 29.80 | 10 % | | Coated tablets: Hydrochlorothiazidum 12.5 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Olmesartan-HCT-Mepha Teva
20/12.5 mg | 98 | 31.82 | 51.05 | 10 % | | Coated tablets: Hydrochlorothiazidum 12.5 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Olmesartan-HCT-Mepha Teva
40/12.5 mg | 98 | 40.59 | 60.60 | 10 % | | Coated tablets: Hydrochlorothiazidum 12.5 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Olmesartan-HCT-Mepha Teva
20/25 mg | 28 | 10.70 | 28.05 | 10 % | | Coated tablets: Hydrochlorothiazidum 25 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Olmesartan-HCT-Mepha Teva
40/25 mg | 28 | 13.65 | 31.25 | 10 % | | Coated tablets: Hydrochlorothiazidum 25 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Olmesartan-HCT-Mepha Teva
20/25 mg | 98 | 31.82 | 51.05 | 10 % | | Coated tablets: Hydrochlorothiazidum 25 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Olmesartan-HCT-Mepha Teva
40/25 mg | 98 | 40.59 | 60.60 | 10 % | | Coated tablets: Hydrochlorothiazidum 25 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Votum plus 20/12.5 | 50 Tablet(s) | | | k.A. | | Coated tablets: 2 Active Agents | A. Menarini GmbH | B | FB | G |
| | | IP | CI | | Votum plus 20/25 | 50 Tablet(s) | | | k.A. | | Coated tablets: 2 Active Agents | A. Menarini GmbH | B | FB | G |
| | SIP | IP | CI | | Olmetec Plus 20/12,5 | 50 Tablet(s) | | | k.A. | | Coated tablets: 2 Active Agents | Daiichi Sankyo
(Schweiz) AG | B | FB | G |
| | SIP | IP | CI | | Olmetec Plus 20/25 | 50 Tablet(s) | | | k.A. | | Coated tablets: 2 Active Agents | Daiichi Sankyo
(Schweiz) AG | B | FB | G |
| | SIP | IP | CI | | Olmetec Plus 40/12,5 | 50 Tablet(s) | | | k.A. | | Coated tablets: 2 Active Agents | Daiichi Sankyo
(Schweiz) AG | B | FB | G |
| | SIP | IP | CI | | Olmetec Plus 40/25 | 50 Tablet(s) | | | k.A. | | Coated tablets: 2 Active Agents | Daiichi Sankyo
(Schweiz) AG | B | FB | G |
| | | IP | CI | | Votum plus 40/12.5 | 50 Tablet(s) | | | k.A. | | Coated tablets: 2 Active Agents | A. Menarini GmbH | B | FB | G |
| | | IP | CI | | Votum plus 40/25 | 50 Tablet(s) | | | k.A. | | Coated tablets: 2 Active Agents | A. Menarini GmbH | B | FB | G |
